Area of expertise: Approval pathways and commercialization of antibacterial drugs

Antoine Andremont

Antoine Andremont

Emeritus Professor
Paris Diderot University Medical School
more
Radu Botgros

Radu Botgros

Senior Scientific Officer
European Medicines Agency
more
Helen W. Boucher

Helen W. Boucher

Professor of Medicine, Director, Infectious Disease Fellowship Program
Tufts Medical Center
more
Marco Cavaleri

Marco Cavaleri

Head of the office of biological health threats and vaccines strategy
European Medicines Agency (EMA)
more
Aleksandar Danilovski

Aleksandar Danilovski

Chief Scientific Officer
Xellia Pharmaceuticals
more
Michael N. Dudley

Michael N. Dudley

President and Chief Executive Officer
Qpex Biopharma
more
Barry I. Eisenstein

Barry I. Eisenstein

Chair, Scientific Advisory Board
CARB-X
more
Sanjay Garg

Sanjay Garg

Director
Centre for Diagnostics and Therapeutics
more
Mark J. Goldberger

Mark J. Goldberger

Independant Consultant
more
Christopher M. Longshaw

Christopher M. Longshaw

Senior Director, Scientific Affairs.
Shionogi B.V.
more

Newsletter

Subscribe to our newsletter to stay up-to-date about our webinars, conferences and other activities.



View previous newsletter

Go to Top